Sam Brusco, Associate Editor06.04.24
ZSFab announced the first clinical case using its recently launched InterConnect 3D-printed Ti lumbar interbody system.
Spine surgeons Dr. Daniel Harwell and Dr. Michael Thambuswamy of the Oklahoma Spine & Brain Institute successfully finished the first three spinal surgeries at Tulsa Spine & Specialty Hospital. The surgeries used ZSFab’s digitally structured P-TLIF interbodies designed with porous titanium.
The implants tout a combination of triply periodic minimal surface (TPMS) and stochastic lattice structures. These are designed to boost osseointegration and promote faster, more robust fusion by mimicking bone’s natural architecture, according to the company.
“I extend my heartfelt gratitude to Drs. Thambuswamy and Harwell for their trust in our technology,” said ZSFab’s CEO, Jing Zhang, Ph.D. “Their pioneering use of our P-TLIF interbody cages marks a significant milestone in advancing spinal surgery. Surgeon partnerships like theirs are invaluable; they not only help bring innovative solutions to the market but also provide critical feedback, driving the continuous evolution of our products to benefit patients worldwide."
Dr. Harwell said ZSFab’s digital design and optimization platform for implants incorporates clinical needs from the early research phase. “I believe this approach enhances innovation efficiency and ultimately ensures excellent long-term patient outcomes," he said.
Dr. Thambuswamy added, "I am impressed by ZSFab’s expertise in innovating implant products. As one of the earliest users of their cervical and lumbar cages, I look forward to seeing more groundbreaking products from them that will benefit our patients.”
Spine surgeons Dr. Daniel Harwell and Dr. Michael Thambuswamy of the Oklahoma Spine & Brain Institute successfully finished the first three spinal surgeries at Tulsa Spine & Specialty Hospital. The surgeries used ZSFab’s digitally structured P-TLIF interbodies designed with porous titanium.
The implants tout a combination of triply periodic minimal surface (TPMS) and stochastic lattice structures. These are designed to boost osseointegration and promote faster, more robust fusion by mimicking bone’s natural architecture, according to the company.
“I extend my heartfelt gratitude to Drs. Thambuswamy and Harwell for their trust in our technology,” said ZSFab’s CEO, Jing Zhang, Ph.D. “Their pioneering use of our P-TLIF interbody cages marks a significant milestone in advancing spinal surgery. Surgeon partnerships like theirs are invaluable; they not only help bring innovative solutions to the market but also provide critical feedback, driving the continuous evolution of our products to benefit patients worldwide."
Dr. Harwell said ZSFab’s digital design and optimization platform for implants incorporates clinical needs from the early research phase. “I believe this approach enhances innovation efficiency and ultimately ensures excellent long-term patient outcomes," he said.
Dr. Thambuswamy added, "I am impressed by ZSFab’s expertise in innovating implant products. As one of the earliest users of their cervical and lumbar cages, I look forward to seeing more groundbreaking products from them that will benefit our patients.”